GENEVA, Feb. 11 -- CYMABAY THERAPEUTICS, INC. (c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404) filed a patent application (PCT/US2025/040038) for "SELADELPAR FOR USE IN TREATING LIVER DISEASE" on Jul 31, 2025. With publication no. WO/2026/030533, the details related to the patent application was published on Feb 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CARROLL, Susheela Y. (CymaBay Therapeutics, Inc.c/o Gilead Sciences, Inc.333 Lakeside DriveFoster City, California 94404), CHOI, Yun-Jung (CymaBay Therapeutics, Inc.c/o Gilead Sciences, Inc.333 Lakeside Dri...